First-in-man phase 1 study of TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors. (December 2016) - Doi, T.; Yoh, K.; Shitara, K.; Takahashi, H.; Ueno, M.; Ohkawa, S.; Morimoto, M.; Kobayashi, S.; Okusaka, T.; Ueno, H.; Morizane, C.; Shiba, S.; et al.